Prenatal and neonatal screening of haemoglobinopathies: a prospective study

Completed

• Conditions: Haemoglobinopathies; Haematological Disorders; Other hereditary haemolytic anaemias

• Registration Number: ISRCTN88941850
• Lead Sponsor: HagaZiekenhuis (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-04-28
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 2000

Inclusion Criteria

1. Pregnant females before the 16th week of pregnancy and newborns
2. Informed consent

Exclusion Criteria

Known haemoglobinopathy

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Carrier frequence of haemoglobinopathies.

Secondary Outcome Measures

Name	Time	Method
1. Serum ferritin<br>2. Compliance to prenatal testing<br>3. Cost-effectiveness